This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 246

Podcast

Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking EP 246Guest: Jill M. Terrien, PhD, ANP-BC
Music Credit: Richard Onorato

Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients. 

Episode Resources and Links: 

  • Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/

Begin

Already listened on another platform?

Claim Credits

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 10/18/2021

Expiration Date: 10/18/2022

Topics

Learning Objectives

  • Discuss the efficacy and safety of muscle relaxants in the treatment of low back pain
  • Describe the overall use of muscle relaxants in the treatment of low back pain 
     

     

 

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Jill M. Terrien, PhD, ANP-BC

Associate Professor, Director NP Programs
UMMS-GSN 

Learn More

Supporters and Partners

Supported by

Not Applicable

Education Partner

Not Applicable

Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking EP 246

Begin